Super Religare Laboratories Limited

India Health

Super Religare Laboratories Limited is one of the leading pathology laboratory networks in India, servicing nearly 1550 hospitals/path labs and over 50,000 doctors.

This investment was made under a previous strategy. We disclose information on all our current investments, but narrative information on our pre-2012 investments, when we introduced a new strategy, may be limited.

We are invested in Super Religare Laboratories Limited through Resurgence PE Investments Ltd (formerly Avigo SME Fund III), which is managed by Avigo Capital Partners. For further information on the fund, the fund manager, and the expected impact of the fund’s investment, click here.

Key facts


Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.

South Asia

We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people.

Investment type

We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).

Intermediated investment
Resurgence PE Investments Ltd (formerly Avigo SME Fund III)
Fund Manager:
Avigo Capital Partners
Start date

For direct investments, this is the date CDC committed capital to the business or project.

For funds, this is the date that CDC committed capital to the fund.

For underlying fund investments, this is the date that the fund invested capital into the business.e

April 2011

This is the investee company’s place of incorporation; or a fund’s jurisdiction.